Cargando…
Interplay of m(6)A and histone modifications contributes to temozolomide resistance in glioblastoma
BACKGROUND: Despite the development of new treatment protocols for glioblastoma (GBM), temozolomide (TMZ) resistance remains a primary hindrance. Previous studies, including our study, have shown that aberrant N6‐methyladenosine (m(6)A) modification is implicated in GBM pathobiology. However, the ro...
Autores principales: | Li, Fuxi, Chen, Siyun, Yu, Jiaming, Gao, Zhuoxing, Sun, Zhangyi, Yi, Yang, Long, Teng, Zhang, Chuanxia, Li, Yuzhe, Pan, Yimin, Qin, Chaoying, Long, Wenyong, Liu, Qing, Zhao, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441140/ https://www.ncbi.nlm.nih.gov/pubmed/34586728 http://dx.doi.org/10.1002/ctm2.553 |
Ejemplares similares
-
Novel Molecular Hallmarks of Group 3 Medulloblastoma by Single-Cell Transcriptomics
por: Qin, Chaoying, et al.
Publicado: (2021) -
Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma
por: Zhao, Zijin, et al.
Publicado: (2021) -
The interplay of histone modifications – writers that read
por: Zhang, Tianyi, et al.
Publicado: (2015) -
RNA N6-Methyladenosine Regulator-Mediated Methylation Modifications Pattern and Immune Infiltration Features in Glioblastoma
por: Pan, Yimin, et al.
Publicado: (2021) -
Histone 2A Family Member J Drives Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Multiforme
por: Lee, Hsun-Hua, et al.
Publicado: (2019)